Airway epithelial expression of TLR5 is downregulated in healthy smokers and smokers with chronic obstructive pulmonary disease

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2217-2225

  Wang, Rui ^a   Ahmed, Joumana ^a   Wang, Guoqing ^a   Hassan, Ibrahim ^a   Strulovici Barel, Yael ^a   Salit, Jacqueline ^a   Mezey, Jason G ^a,b   Crystal, Ronald G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; INTERLEUKIN 6; INTERLEUKIN 8; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 8;

ADULT; ARTICLE; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; INFECTION SENSITIVITY; INNATE IMMUNITY; LUNG ALVEOLUS EPITHELIUM; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RECEPTOR DOWN REGULATION; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; FEMALE; FLAGELLIN; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY MUCOSA; SMOKING; TOLL-LIKE RECEPTOR 5;

EID: 84865405120     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101895     Document Type: Article

References (59)

1. Medzhitov, R., and C. A. Janeway, Jr. 2002. Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300.
2. Ryu, J. H., C. H. Kim, and J. H. Yoon. 2010. Innate immune responses of the airway epithelium. Mol. Cells 30: 173-183.
3. Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17: 1-14.
4. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
5. Kang, J. Y., and J. O. Lee. 2011. Structural biology of the Toll-like receptor family. Annu. Rev. Biochem. 80: 917-941.
6. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
7. Leulier, F., and B. Lemaitre. 2008. Toll-like receptors - taking an evolutionary approach. Nat. Rev. Genet. 9: 165-178.
8. Kato, A., and R. P. Schleimer. 2007. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr. Opin. Immunol. 19: 711-720.
9. Dunne, A., and L. A. O'Neill. 2005. Adaptor usage and Toll-like receptor signaling specificity. FEBS Lett. 579: 3330-3335.
10. Zhang, Z., J. P. Louboutin, D. J. Weiner, J. B. Goldberg, and J. M. Wilson. 2005. Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect. Immun. 73: 7151-7160.
11. Smith, K. D., E. Andersen-Nissen, F. Hayashi, K. Strobe, M. A. Bergman, S. L. Barrett, B. T. Cookson, and A. Aderem. 2003. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4: 1247-1253.
12. Blohmke, C. J., R. E. Victor, A. F. Hirschfeld, I. M. Elias, D. G. Hancock, C. R. Lane, A. G. Davidson, P. G. Wilcox, K. D. Smith, J. Overhage, et al. 2008. Innate immunity mediated by TLR5 as a novel antiinflammatory target for cystic fibrosis lung disease. J. Immunol. 180: 7764-7773.
13. Janot, L., J. C. Sirard, T. Secher, N. Noulin, L. Fick, S. Akira, S. Uematsu, A. Didierlaurent, T. Hussell, B. Ryffel, and F. Erard. 2009. Radioresistant cells expressing TLR5 control the respiratory epithelium's innate immune responses to flagellin. Eur. J. Immunol. 39: 1587-1596.
14. Feuillet, V., S. Medjane, I. Mondor, O. Demaria, P. P. Pagni, J. E. Galán, R. A. Flavell, and L. Alexopoulou. 2006. Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria. Proc. Natl. Acad. Sci. USA 103: 12487-12492.
15. Wang, R., G. Wang, M. J. Ricard, B. Ferris, Y. Strulovici-Barel, J. Salit, N. R. Hackett, L. J. Gudas, and R. G. Crystal. 2010. Smoking-induced upregulation of AKR1B10 expression in the airway epithelium of healthy individuals. Chest 138: 1402-1410.
16. Harvey, B. G., A. Heguy, P. L. Leopold, B. J. Carolan, B. Ferris, and R. G. Crystal. 2007. Modification of gene expression of the small airway epithelium in response to cigarette smoking. J. Mol. Med. 85: 39-53.
17. Rabe, K. F., S. Hurd, A. Anzueto, P. J. Barnes, S. A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R. Rodriguez-Roisin, C. vanWeel, and J. Zielinski; Global Initiative for Chronic Obstructive Lung Disease. 2007. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am. J. Respir. Crit. Care Med. 176: 532-555.
18. Pauwels, R. A., A. S. Buist, P. M. Calverley, C. R. Jenkins, and S. S. Hurd; GOLD Scientific Committee. 2001. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 163: 1256-1276.
19. Raman, T., T. P. O'Connor, N. R. Hackett, W. Wang, B. G. Harvey, M. A. Attiyeh, D. T. Dang, M. Teater, and R. G. Crystal. 2009. Quality control in microarray assessment of gene expression in human airway epithelium. BMC Genomics 10: 493.
20. Hackett, N. R., M. W. Butler, R. Shaykhiev, J. Salit, L. Omberg, J. L. Rodriguez-Flores, J. G. Mezey, Y. Strulovici-Barel, G. Wang, L. Didon, and R. G. Crystal. 2012. RNA-Seq quantification of the human small airway epithelium transcriptome. BMC Genomics 13: 82.
21. Langmead, B., C. Trapnell, M. Pop, and S. L. Salzberg. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10: R25.
22. Mortazavi, A., B. A. Williams, K. McCue, L. Schaeffer, and B. Wold. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5: 621-628.
23. Wallenius, K., K. Sjögren, X. D. Peng, S. Park, V. Wallenius, J. L. Liu, M. Umaerus, H. Wennbo, O. Isaksson, L. Frohman, et al. 2001. Liver-derived IGF-I regulates GH secretion at the pituitary level in mice. Endocrinology 142: 4762-4770.
24. Hackett, N. R., R. Shaykhiev, M. S. Walters, R. Wang, R. K. Zwick, B. Ferris, B. Witover, J. Salit, and R. G. Crystal. 2011. The human airway epithelial basal cell transcriptome. PLoS ONE 6: e18378.
25. Schaich, E., and A. Hamerle. 1984. Verteilungsfreie statistische Prüfverfahren. Springer, Berlin.
26. MacRedmond, R. E., C. M. Greene, D. R. Dorscheid, N. G. McElvaney, and S. J. O'Neill. 2007. Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke. Respir. Res. 8: 84.
27. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
28. Barton, G. M., and R. Medzhitov. 2003. Toll-like receptor signaling pathways. Science 300: 1524-1525.
29. Arcavi, L., and N. L. Benowitz. 2004. Cigarette smoking and infection. Arch. Intern. Med. 164: 2206-2216.
30. Murin, S., and K. S. Bilello. 2005. Respiratory tract infections: another reason not to smoke. Cleve. Clin. J. Med. 72: 916-920.
31. Qvarfordt, I., G. C. Riise, B. A. Andersson, and S. Larsson. 2000. Lower airway bacterial colonization in asymptomatic smokers and smokers with chronic bronchitis and recurrent exacerbations. Respir. Med. 94: 881-887.
32. Lemaitre, B. 2004. The road to Toll. Nat. Rev. Immunol. 4: 521-527.
33. Kumar, H., T. Kawai, and S. Akira. 2009. Pathogen recognition in the innate immune response. Biochem. J. 420: 1-16.
34. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
35. Werts, C., R. I. Tapping, J. C. Mathison, T. H. Chuang, V. Kravchenko, I. Saint Girons, D. A. Haake, P. J. Godowski, F. Hayashi, A. Ozinsky, et al. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2: 346-352.
36. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752.
37. Town, T., D. Jeng, L. Alexopoulou, J. Tan, and R. A. Flavell. 2006. Microglia recognize double-stranded RNA via TLR3. J. Immunol. 176: 3804-3812.
38. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer. 2004. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
39. Gorden, K. K., X. Qiu, J. J. Battiste, P. P. Wightman, J. P. Vasilakos, and S. S. Alkan. 2006. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines. J. Immunol. 177: 8164-8170.
40. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
41. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
42. Wesche, H., W. J. Henzel, W. Shillinglaw, S. Li, and Z. Cao. 1997. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7: 837-847.
43. Moynagh, P. N. 2005. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 26: 469-476.
44. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165: 5392-5396.
45. Wang, X., C.Moser, J. P. Louboutin, E. S. Lysenko, D. J. Weiner, J. N. Weiser, and J. M. Wilson. 2002. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol. 168: 810-815.
46. Vijay-Kumar, M., C. J. Sanders, R. T. Taylor, A. Kumar, J. D. Aitken, S. V. Sitaraman, A. S. Neish, S. Uematsu, S. Akira, I. R. Williams, and A. T. Gewirtz. 2007. Deletion of TLR5 results in spontaneous colitis in mice. J. Clin. Invest. 117: 3909-3921.
47. Letran, S. E., S. J. Lee, S. M. Atif, A. Flores-Langarica, S. Uematsu, S. Akira, A. F. Cunningham, and S. J. McSorley. 2011. TLR5-deficient mice lack basal inflammatory and metabolic defects but exhibit impaired CD4 T cell responses to a flagellated pathogen. J. Immunol. 186: 5406-5412.
48. Bals, R., and P. S. Hiemstra. 2004. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23: 327-333.
49. Shanks, K. K., W. Guang, K. C. Kim, and E. P. Lillehoj. 2010. Interleukin-8 production by human airway epithelial cells in response to Pseudomonas aeruginosa clinical isolates expressing type a or type b flagellins. Clin. Vaccine Immunol. 17: 1196-1202.
50. Im, J., J. H. Jeon, M. K. Cho, S. S. Woo, S. S. Kang, C. H. Yun, K. Lee, D. K. Chung, and S. H. Han. 2009. Induction of IL-8 expression by bacterial flagellin is mediated through lipid raft formation and intracellular TLR5 activation in A549 cells. Mol. Immunol. 47: 614-622.
51. Hongjia, L., G. Qingling, L. Meiying, W. Weixuan, Z. Lihong, G. Yongsheng, L. Yanli, W. Jinxiang, and D. Liang. 2010. House dust mite regulate the lung inflammation of asthmatic mice through TLR4 pathway in airway epithelial cells. Cell Biochem. Funct. 28: 597-603.
52. Berndt, A., F. J. Derksen, P. J. Venta, S. Ewart, V. Yuzbasiyan-Gurkan, and N. E. Robinson. 2007. Elevated amount of Toll-like receptor 4 mRNA in bronchial epithelial cells is associated with airway inflammation in horses with recurrent airway obstruction. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L936-L943.
53. John, G., A. O. Yildirim, B. K. Rubin, D. C. Gruenert, and M. O. Henke. 2010. TLR-4-mediated innate immunity is reduced in cystic fibrosis airway cells. Am. J. Respir. Cell Mol. Biol. 42: 424-431.
54. Almagro, P., M. Salvadó, C. Garcia-Vidal, M. Rodríguez- Carballeira, E. Cuchi, J. Torres, and J. Ll Heredia. 2011. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease. Respiration. In press.
55. Döring, G., I. G. Parameswaran, and T. F. Murphy. 2011. Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease. FEMS Microbiol. Rev. 35: 124-146.
56. Li, X. J., Q. Li, L. Y. Si, and Q. Y. Yuan. 2011. Bacteriological differences between COPD exacerbation and community-acquired pneumonia. Respir. Care 56: 1818-1824.
57. Murphy, T. F., A. L. Brauer, K. Eschberger, P. Lobbins, L. Grove, X. Cai, and S. Sethi. 2008. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 177: 853-860.
58. Murphy, T. F. 2009. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 15: 138-142.
59. Maunders, H., S. Patwardhan, J. Phillips, A. Clack, and A. Richter. 2007. Human bronchial epithelial cell transcriptome: gene expression changes following acute exposure to whole cigarette smoke in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1248-L1256.